JP2017503749A5 - - Google Patents

Download PDF

Info

Publication number
JP2017503749A5
JP2017503749A5 JP2016519779A JP2016519779A JP2017503749A5 JP 2017503749 A5 JP2017503749 A5 JP 2017503749A5 JP 2016519779 A JP2016519779 A JP 2016519779A JP 2016519779 A JP2016519779 A JP 2016519779A JP 2017503749 A5 JP2017503749 A5 JP 2017503749A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
cyclic
acyclic
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016519779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017503749A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/058680 external-priority patent/WO2015051030A2/en
Publication of JP2017503749A publication Critical patent/JP2017503749A/ja
Publication of JP2017503749A5 publication Critical patent/JP2017503749A5/ja
Pending legal-status Critical Current

Links

JP2016519779A 2013-10-01 2014-10-01 安定化されたポリペプチドおよびその使用 Pending JP2017503749A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361885384P 2013-10-01 2013-10-01
US61/885,384 2013-10-01
US201461934618P 2014-01-31 2014-01-31
US61/934,618 2014-01-31
PCT/US2014/058680 WO2015051030A2 (en) 2013-10-01 2014-10-01 Stabilized polypeptides and uses thereof

Publications (2)

Publication Number Publication Date
JP2017503749A JP2017503749A (ja) 2017-02-02
JP2017503749A5 true JP2017503749A5 (cg-RX-API-DMAC7.html) 2018-08-30

Family

ID=52779285

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016519779A Pending JP2017503749A (ja) 2013-10-01 2014-10-01 安定化されたポリペプチドおよびその使用

Country Status (6)

Country Link
US (1) US20160244494A1 (cg-RX-API-DMAC7.html)
EP (1) EP3052520A4 (cg-RX-API-DMAC7.html)
JP (1) JP2017503749A (cg-RX-API-DMAC7.html)
CN (1) CN106103472A (cg-RX-API-DMAC7.html)
IL (1) IL244810A0 (cg-RX-API-DMAC7.html)
WO (1) WO2015051030A2 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192713B1 (en) 1999-05-18 2007-03-20 President And Fellows Of Harvard College Stabilized compounds having secondary structure motifs
CA2677045C (en) 2007-01-31 2016-10-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
CA2682174C (en) 2007-03-28 2021-04-06 President And Fellows Of Harvard College Stitched polypeptides
WO2012021875A1 (en) 2010-08-13 2012-02-16 Aileron Therapeutics, Inc. Peptidomimetic macrocycles with triazole linkers
CN108929375A (zh) 2011-10-18 2018-12-04 爱勒让治疗公司 拟肽大环化合物
CA2864120A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
CN112500466B (zh) 2012-02-15 2022-05-03 艾瑞朗医疗公司 拟肽大环化合物
WO2014138429A2 (en) 2013-03-06 2014-09-12 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and use thereof in regulating hif1alpha
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
US10905739B2 (en) 2014-09-24 2021-02-02 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
EP3197478A4 (en) 2014-09-24 2018-05-30 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
SG11201707750YA (en) 2015-03-20 2017-10-30 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
WO2017004548A1 (en) 2015-07-01 2017-01-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
WO2018089648A2 (en) 2016-11-09 2018-05-17 Ohio State Innovation Foundation Di-sulfide containing cell penetrating peptides and methods of making and using thereof
US11352394B2 (en) 2016-11-22 2022-06-07 Ohio State Innovation Foundation Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof
US10913773B2 (en) 2016-11-22 2021-02-09 Ohio State Innovation Foundation Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha
BR112020004555A2 (pt) 2017-09-07 2020-09-24 Fog Pharmaceuticals, Inc. agentes que modulam funções de beta-catenina e métodos dos mesmos
WO2019070962A1 (en) 2017-10-04 2019-04-11 Ohio State Innovation Foundation BICYCLIC PEPTIDE INHIBITORS
AU2018385697B2 (en) 2017-12-15 2023-11-09 Dana-Farber Cancer Institute, Inc. Stabilized peptide-mediated targeted protein degradation
WO2019136209A1 (en) * 2018-01-05 2019-07-11 President And Fellows Of Harvard College Stabilized polypeptides and uses thereof
WO2019148195A2 (en) 2018-01-29 2019-08-01 Ohio State Innovation Foundation Cyclic peptidyl inhibitors of cal-pdz binding domain
EP3749678A1 (en) 2018-02-07 2020-12-16 Dana Farber Cancer Institute, Inc. Cell-permeable stapled peptide modules for cellular delivery
US11987647B2 (en) 2018-05-09 2024-05-21 Ohio State Innovation Foundation Cyclic cell-penetrating peptides with one or more hydrophobic residues
US11091522B2 (en) 2018-07-23 2021-08-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
CA3110082A1 (en) 2018-08-20 2020-02-27 Fog Pharmaceuticals, Inc. Collections of peptides, peptide agents, and methods of use thereof
US20230174576A1 (en) * 2020-10-30 2023-06-08 Xeno-Interface Inc. Beta-strand bridge peptide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1282722B1 (en) * 1999-10-15 2011-06-15 Avatar Medical, L.L.C. Stabilized proteins
WO2005044839A2 (en) * 2003-11-05 2005-05-19 Dana-Farber Cancer Institute, Inc. Stabilized alpha helical peptides and uses thereof
DK1689863T3 (da) * 2003-11-15 2014-08-25 Polyphor Ltd Template-fikserede beta-hairpinloopmimetika og deres anvendelse i fag-display
US7202332B2 (en) * 2004-05-27 2007-04-10 New York University Methods for preparing internally constrained peptides and peptidomimetics
US20060148715A1 (en) * 2004-12-20 2006-07-06 Baylor College Of Medicine Structural requirements for STAT3 binding and recruitment to phosphotyrosine ligands
CA2682174C (en) * 2007-03-28 2021-04-06 President And Fellows Of Harvard College Stitched polypeptides
US20110144306A1 (en) * 2008-07-23 2011-06-16 President And Fellows Of Harvard College Ligation of stapled polypeptides
CA2768299C (en) * 2009-07-13 2018-03-20 President And Fellows Of Harvard College Bifunctional stapled polypeptides and uses thereof
US20130177979A1 (en) * 2010-06-22 2013-07-11 University Of Central Florida Research Foundation, Inc. Methods and compositions for cell permeable stat3 inhibitor

Similar Documents

Publication Publication Date Title
JP2017503749A5 (cg-RX-API-DMAC7.html)
JP7490735B2 (ja) ジスルフィド含有細胞膜透過ペプチド並びにその製造方法及び使用方法
ES2654551T3 (es) Anticuerpo contra el CSF-1R
FI3354729T3 (fi) Anti-garp-vasta-aine
ES2882634T3 (es) Compuestos peptídicos y conjugados con péptidos para el tratamiento del cáncer mediante quimioterapia mediada por receptores
Baumruck et al. Chemical synthesis of membrane proteins: a model study on the influenza virus B proton channel
CN111420045B (zh) 免疫受体调节剂偶联体及其制备方法和应用、制备其的偶联前体以及合成偶联前体的化合物
CN102510755A (zh) 双功能钉接多肽和其用途
ITMI20100093A1 (it) Peptidi ciclici che legano il recettore cxcr4 e relativi usi in campo medico e diagnostico
JP2023134675A (ja) ステープルペプチドの細胞内送達のためのポリペプチド接合体
Aronov et al. Nuclear localization signal-targeted poly (ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues
CN104130315A (zh) 一种特异靶向her2蛋白的多肽
CN116731113A (zh) 针对sort1的多肽化合物及其药物偶联物
Li et al. Greener liquid-phase synthesis and the ACE inhibitory structure–activity relationship of an anti-SARS octapeptide
US10258695B2 (en) Protein derivatization to endow cell penetration
Tung et al. Peptide 2-formylthiophenol esters do not proceed through a Ser/Thr ligation pathway, but participate in a peptide aminolysis to enable peptide condensation and cyclization
Mandal et al. Structure–activity studies of phosphopeptidomimetic prodrugs targeting the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3 (Stat3)
JPWO2015125892A1 (ja) 蛋白質の標識化合物
JP7687711B2 (ja) ネイティブケミカルライゲーションを用いる新規フロー合成方法
CN109553590B (zh) 具有谷胱甘肽巯基转移酶抑制功能的化合物及其制备方法
WO2017190061A1 (en) Synthetic dna binding domain peptides and uses thereof
Atkinson et al. Development of small cyclic peptides targeting the CK2α/β interface
JP6707783B2 (ja) ペプチド化合物及びペプチド化合物の製造方法
WO2019072231A1 (zh) 核磁共振显像化合物、核磁共振显像剂及应用、以及核磁共振成像方法
CN104017047A (zh) 一种肽基取代双链苯并呋喃喹啉衍生物及其制备方法和应用